Leite John's Form 4 filing
Veracyte, Inc. (VCYT) · filed Mar 10, 2025
- Accession no.
- 0001384101-25-000042
- Filed
- Mar 10, 2025
- Trade date
- Mar 6-7, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $234.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leite JohnCIK 0001991536 | Officer (Chief Commercial Officer-CLIA) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | Common Stock | AGrant or awardAcquired | +36,240 | $0.00 | $0 | 107,660 | Direct | |
| Mar 7, 2025 | Common Stock | SSaleDisposed | −2,400 | $31.04F3 | −$74,496 | 105,260 | Direct | |
| Mar 7, 2025 | Common Stock | SSaleDisposed | −5,011 | $31.96F4 | −$160,151.56 | 100,249 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents weighted average sales price. Sale prices for the transactions range from $30.63 to $31.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Represents weighted average sales price. Sale prices for the transactions range from $31.71 to $32.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Referenced by the price of 1 transaction in Table I.